Halozyme Therapeutics, Inc. (HALO) Fell Out Of Favor With Hedge Funds
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Posts Tagged ‘NASDAQ:HALO’
Hedge Funds Are Cashing Out Of Halozyme Therapeutics, Inc. (HALO)
In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now.
Is HALO Stock A Buy or Sell?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Is Halozyme Therapeutics (HALO) A Smart Long-Term Buy?
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2020 investor letter – a copy ...
Hedge Funds Are Getting Bullish On Halozyme Therapeutics, Inc. (HALO)
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Did Hedge Funds Make The Right Call On Halozyme Therapeutics, Inc. (HALO) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About Halozyme Therapeutics, Inc. (HALO)
In this article you are going to find out whether hedge funds think Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a good investment right now.
Is Halozyme Therapeutics (HALO) a Smart Long-term Buy?
First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Halozyme Therapeutics (HALO) Stock Is Absurdly Cheap Right Now
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so.
Hedge Fund and Insider Trading News: Paul Tudor Jones, Ken Griffin, Anthony Scaramucci, Massar Capital, Prosperity Bancshares, Inc. (PB), MoreHalozyme Therapeutics, Inc. (HALO), and More
BOSTON (Reuters) - Citadel, the Chicago-based hedge fund giant led by billionaire Ken Griffin, has so far weathered the coronavirus market storm well, turning a slight profit ...
Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)
"Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much.
is Halozyme Therapeutics, Inc. (HALO) Going To Burn These Hedge Funds?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.
Is Halozyme Therapeutics, Inc. (HALO) A Good Stock To Buy?
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and ...
Here’s What Hedge Funds Think About Halozyme Therapeutics, Inc. (HALO) Anymore
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Hedge Funds Are Betting On Halozyme Therapeutics, Inc. (HALO)
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Financial Markets Snapshot: 35 Fresh Stories Telling How is it Going in the Finance World Today
"U.S. equities traded higher on Friday as concerns about Donald Trump's presidency recede for the time being.
Is Halozyme Therapeutics, Inc. (HALO) Worthy of Your Portfolio?
Hedge fund managers like David Einhorn, Dan Loeb, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks...
Yelp Inc (YELP) Swung To Surprising Profit; A Look at Four Other Earnings Reports
No major moves in the US stock market this Wednesday morning, as investors digest retail earnings reports and are keeping an eye on oil prices.
Small Companies, Big Declines: Why These Stocks Tumbled Today
The markets can’t seem to catch a break in 2016; on Wednesday, all major U.S stock indexes continued to decline.
The News that Prompted Furious Trading in These 4 Stocks Today
Sientra Inc (NASDAQ:SIEN), Select Medical Holdings Corporation (NYSE:SEM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), and Micron Technology, Inc.
Hedge Funds Are Buying Halozyme Therapeutics, Inc. (HALO)
How do we determine whether Halozyme Therapeutics, Inc.
Insiders and Hedge Funds Were Right About Halozyme Therapeutics, Inc. (HALO); Now They Are Buying More
David Cohen and Harold Levy of Iridian Asset Management have significantly increased their stake in Halozyme Therapeutics, Inc.
How QVT Financial Gained from Lumber Liquidators Holdings Inc (LL)’s 53% Drop in Q1
As a new filing with the Securities and Exchange Commission shows, Daniel Gold's QVT Financial has initiated a passive stake in Aehr Test Systems (NASDAQ:AEHR).
Sanofi SA (ADR) (SNY), Shire PLC (ADR) (SHPG): Making Sense of the Drama About Viropharma Inc (VPHM)
In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well-known for its hefty acquisition...
Hedge Funds Are Dumping EXACT Sciences Corporation (EXAS)
In the financial world, there are a multitude of gauges shareholders can use to analyze Mr. Market. Two of the most innovative are hedge fund and insider trading interest.
Hedge Funds Are Buying ACADIA Pharmaceuticals Inc. (ACAD)
In the eyes of many of your fellow readers, hedge funds are viewed as overrated, outdated financial tools of a forgotten age.
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Now, according to many investors, hedge funds are seen as delayed, outdated financial tools of an era lost to time.
Progenics Pharmaceuticals, Inc. (PGNX), Halozyme Therapeutics, Inc. (HALO), Astex Pharmaceuticals, Inc. (ASTX): Three Humongous Health-Care Stocks This Week
With August winding down, summer won't be around much longer. Several health-care stocks still had hot days this past week, though.
Baxter International Inc. (BAX), Halozyme Therapeutics, Inc. (HALO): This Healthcare Company Is Poised for Growth
The performance of Baxter International Inc. (NYSE:BAX), the world’s second-largest maker of dialysis products, has been lagging the market with 7.38% gain YTD as of Aug 2, ...
Halozyme Therapeutics, Inc. (HALO), Viropharma Inc (VPHM): Three Horrendous Health-Care Stocks This Week
One decision led to a double whammy this week for biotech companies Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Viropharma Inc (NASDAQ:VPHM).
Halozyme Therapeutics, Inc. (HALO): Is This Delivery-Focused Biotech a Buy?
Halozyme Therapeutics, Inc. (NASDAQ:HALO) moved higher by 25% on Friday behind the news of a positive opinion by the European Medicines Agency's Committee for Medicinal Products...
Auxilium Pharmaceuticals, Inc. (AUXL): Huge Potential For First Line Therapy For Frozen Shoulder
Xiaflex from Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) is used to treat Dupuytren’s contracture.
Dyax Corp. (DYAX), Shire PLC (ADR) (SHPG): An Interesting Bio Play in the Blood Disorder Niche
Thousands of Americans suffer from a rare and painful disease every year. This inherited disease is called Hereditary Angioedema, or HAE for short.
Baxter International Inc. (BAX) Healthcare Stock Checkup
There is plenty of good news to support the 30% move made by Baxter International Inc. (NYSE:BAX) shares in the past year.
Here is What Hedge Funds Think About ACADIA Pharmaceuticals Inc. (ACAD)
To most market participants, hedge funds are viewed as underperforming, outdated financial vehicles of the past.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock?
To the average investor, there are a multitude of metrics market participants can use to track stocks. A pair of the most useful are hedge fund and insider trading movement.
Bristol Myers Squibb Co. (BMY), Gilead Sciences, Inc. (GILD), Halozyme Therapeutics, Inc. (HALO): 3 Stocks to Watch Ahead of ASCO
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Should You Avoid ACADIA Pharmaceuticals Inc. (ACAD)?
To most traders, hedge funds are seen as unimportant, outdated investment tools of the past.
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
ACADIA Pharmaceuticals Inc. (ACAD): Insiders Are Dumping, Should You?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was in 12 hedge funds' portfolio at the end of the fourth quarter of 2012.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? – Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)
To most stock holders, hedge funds are perceived as worthless, old financial vehicles of years past.
3 Horrendous Health-Care Stocks This Week: Rigel Pharmaceuticals, Inc. (RIGL), Achillion Pharmaceuticals, Inc. (ACHN)
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode.
Micron Technology, Inc. (MU), Pfizer Inc. (PFE): Whoa! These Stocks Outpaced the Dow
The Dow Jones Industrial Average rose by 90 points on Friday -- the exact amount it fell the day before -- on hopes that a deal between the European Union and Cyprus would get...
3 Horrendous Health-Care Stocks This Week: Herbalife Ltd. (HLF), Celsion Corporation (CLSN) and More
It's hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care stocks crashing.
